HTG Molecular Diagnostics Inc

NASDAQ:HTGM   11:36:07 AM EDT
3.83
+0.11 (+2.96%)
Earnings Announcements

HTG Molecular Diagnostics Reports Full Year 2020 Results

Published: 03/25/2021 21:39 GMT
HTG Molecular Diagnostics Inc (HTGM) - Htg Molecular Diagnostics Reports Full Year 2020 Results.
Htg Molecular Diagnostics - Cash, Cash Equivalents, Short-term Available-for-sale Securities Totaled $28.7 Million As of Dec 31, 2020.
Revenue is expected to be $2.35 Million
Adjusted EPS is expected to be -$0.88

Next Quarter Revenue Guidance is expected to be $2.72 Million
Next Quarter EPS Guidance is expected to be -$0.88

More details on our Analysts Page.